Institute of Medicine Expert Committee Assessing Feasibility of Viral Hepatitis Elimination Targets in the U.S. |
March 4, 2016 :: AIDS.gov Blog |
domingo, 6 de marzo de 2016
blog.aids.gov − Institute of Medicine Expert Committee Assessing Feasibility of Viral Hepatitis Elimination Targets in the U.S.
blog.aids.gov − Institute of Medicine Expert Committee Assessing Feasibility of Viral Hepatitis Elimination Targets in the U.S.
![Update from the AIDS.gov Blog](https://blogger.googleusercontent.com/img/proxy/AVvXsEg-DNEaYw3TNNlPA6cxdTAn9DGJD2fwc6KYgfpzwB204_MO9yndXfKd8DawYbwTSpN6_fo1ACC6wKH5D1yjhogWnjN-aZiCoK-KrS-s2bU51649Uigq_D88KIN1e3CtwDTy6bEUzR5UUsN-tCW0ae3yGhoA9oLnhPFLgfSeLaNFkV8Urk7aN7TujbezCZaTsFnRaYANOzrgSN0GctXM-nYq91DgMMZtAWX5xuOlahpydzDkqeg=s0-d-e1-ft)
In 2014, the World Health Organization’s (WHO) World Health Assembly unanimously adopted resolution WHA67.6, which urged Member States and the WHO Director-General to enhance efforts in viral hepatitis surveillance, prevention, treatment access, and disease control. This resolution tasked the WHO with assessing the feasibility of elimination targets for hepatitis B (HBV) and hepatitis C (HCV) viruses. As a result, the WHO is developing a Global Health Sector Strategy on Viral Hepatitis, 2016-2021, due to be released later this year, to guide global action and supplement existing activities in addressing viral hepatitis. [READ MORE]
Suscribirse a:
Enviar comentarios (Atom)
No hay comentarios:
Publicar un comentario